Palopegteriparatide

  • Part D specialty tier in 79% of formularies (2026Q3)
  • Yorvipath

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Palopegteriparatide: storage and handling

Refrigerate
Yes, as the label states
Label statement
Until first use, store YORVIPATH in the refrigerator between 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
up to 14 days at or below 30°C (86°F)
Label statement
After first use, store YORVIPATH for 14 days at room temperature below 30°C (86°F).
Room temperature
up to 14 days at or below 30°C (86°F)
Label statement
After first use, store your pen for 14 days at room temperature below 30°C (86°F).
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Keep YORVIPATH in the packaging to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 14 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

After first use, store YORVIPATH for 14 days at room temperature below 30°C (86°F).
Discard the prefilled pen 14 days after first use.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-844-442-7236 (the number printed on the label) about this product.

Where the label prints this number
6, 9 or 12 mcg doses only ascendis pharma Back Additional information If you need help, please ask your health care provider or nurse for advice or contact the Ascendis Pharma Helpline: Ascendis Pharma Helpline: Toll-free telephone number: 1-844-442-7236 Ascendis Pharma Bone Diseases A/S Tuborg Boulevard 12 DK-2900 Hellerup Denmark ascendis pharma Panel 1 1.
All storage statements on the label (12)
  • Do not freeze.
  • Store away from heat.
  • Keep YORVIPATH in the packaging to protect from light.
  • Until first use, store YORVIPATH in the refrigerator between 2°C to 8°C (36°F to 46°F).
  • After first use, store YORVIPATH for 14 days at room temperature below 30°C (86°F).
  • After each use, remove the needle and put the pen cap on to protect from light.
  • Discard the prefilled pen 14 days after first use.
  • Storing Your Pen Until first use, refrigerate your pens between 2°C to 8°C (36°F to 46°F) and keep in the package to protect from light.
  • After first use, store your pen for 14 days at room temperature below 30°C (86°F).
  • Do not freeze your pen.
  • Store YORVIPATH away from heat.
  • Tip: You should take a new pen out of the refrigerator 20 minutes before first use to allow the medicine to get to room temperature before injecting.

FDA label version 8, effective August 12, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

4%of plans list it
100%of those: prior authorization
0%step therapy
90%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.